Safety, tolerability, and immunogenicity of the ChAdOx1 RVF vaccine against Rift Valley fever among healthy adults in Uganda: a single-centre, single-blind, randomised, placebo-controlled, dose-escalation, phase 1 trial. (linkinghub.elsevier.com)

Authors: Anywaine Z … Kaleebu P Journal: Lancet Infectious Diseases Published: 2026-03-01 DOI: https://doi.org/10.1016/S1473-3099(25)00565-1